CLARK IAN T 4

What Happened
Ian T. Clark, a director of Guardant Health (GH), disposed of 6,876 shares in open‑market transactions on May 20, 2026. The filing reports a weighted‑average sale price of $106.90 per share, for aggregate proceeds of approximately $735,049. This transaction is reported as a sale (code S).

Key Details

• Transaction date: 2026-05-20 (reported on Form 4 filed 2026-05-22).
• Transaction type: Open‑market sale (S), executed in multiple trades.
• Price range: $106.85 to $106.99; weighted average $106.90 (footnote F1).
• Shares sold: 6,876; proceeds ≈ $735,049.
• Shares owned after transaction: Not specified in the provided filing.
• Footnote F1: Indicates the sale occurred in multiple transactions and the reporting person can provide a breakdown of how many shares were sold at each separate price within the stated range upon request.
• Filing timeliness: Filed two days after the trade (appears timely for a Form 4).

Context
This was a straightforward open‑market sale, not an option exercise, award, or gift. Sales by insiders are relatively common for liquidity, diversification, or tax purposes and do not by themselves prove company prospects have changed. Purchases generally carry more weight when interpreting insider conviction; this filing documents a routine liquidation.